Ananth Shankar

6PUBLICATIONS
53CO-AUTHORS
Adolescent healthImmunogenetics (incl. genetic immunology)Predictive and prognostic markersVeterinary pharmacologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 03, 2026
EuroNet-PHL-LP1: complete resection or low-dose chemotherapy for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

|Apr 14, 2026
Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs

|Aug 07, 2023
Deep-learning based classification of a tumor marker for prognosis on Hodgkin's disease.

Ila Motmaen, Sergej Sereda, Alexander Brobeil

|Mar 17, 2023
An illuminating piece in the jigsaw of Hodgkin lymphoma risk stratification.

Ananth Shankar, Jamshed Bomanji

|Apr 01, 2022
Management of children and adults with all stages of nodular lymphocyte predominant Hodgkin lymphoma - All StAGEs: A consensus-based position paper from the Hodgkin lymphoma subgroup of the UK National Cancer Research Institute.

Ananth Shankar, Georgina W Hall, Pam McKay

|Nov 13, 2020
Hybrid PET-MRI Imaging in Paediatric and TYA Brain Tumours: Clinical Applications and Challenges.

Ananth Shankar, Jamshed Bomanji, Harpreet Hyare

Pageof 1

Frequent Collaborators

2 joint publications

Pamela McKay

2 joint publications

Dirk Hasenclever

1 joint publications

Jamie E Flerlage

1 joint publications

Dennis A Eichenauer